Source: 4-traders

Clementia: Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Clementia, Multi-Color, and GTx on Behalf of Stockholders and Encourages Investors to Contact the Firm

(marketscreener.com) NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Clementia Pharmaceuticals Inc., Multi-Color Corporation, and GTx, Inc. Additional information about each potential action can be found at the link provided. Clementia...http://www.marketscreener.com/news/Bragar-Eagel-Squire-P-C-Reminds-Investors-that-it-is-Investigating-the-Boards-of-Directors-of-Cl--28203601/?utm_medium=RSS&utm_content=20190320

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more